Andrea L. Schaffer

2.9k total citations · 1 hit paper
75 papers, 1.7k citations indexed

About

Andrea L. Schaffer is a scholar working on Public Health, Environmental and Occupational Health, Oncology and Economics and Econometrics. According to data from OpenAlex, Andrea L. Schaffer has authored 75 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Public Health, Environmental and Occupational Health, 14 papers in Oncology and 14 papers in Economics and Econometrics. Recurrent topics in Andrea L. Schaffer's work include Opioid Use Disorder Treatment (15 papers), Health Systems, Economic Evaluations, Quality of Life (10 papers) and Pain Management and Opioid Use (9 papers). Andrea L. Schaffer is often cited by papers focused on Opioid Use Disorder Treatment (15 papers), Health Systems, Economic Evaluations, Quality of Life (10 papers) and Pain Management and Opioid Use (9 papers). Andrea L. Schaffer collaborates with scholars based in Australia, United Kingdom and Iceland. Andrea L. Schaffer's co-authors include Sallie‐Anne Pearson, Timothy Dobbins, Nicholas A. Buckley, Benjamin Daniels, Rose Cairns, Melisa Litchfield, Emily A. Karanges, Bianca Blanch, David Muscatello and Wayne Smith and has published in prestigious journals such as PLoS ONE, Pain and British Journal of Cancer.

In The Last Decade

Andrea L. Schaffer

71 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Interrupted time series analysis using autoregressive integrated moving average (ARIMA) models: a guide for evaluating large-scale health interventions

2021 390 citations Andrea L. Schaffer, Timothy Dobbins et al. profile →

Peers

Andrea L. Schaffer

PHEOH

EPIDE

ONCOL

GHP

Ronald J. Halbert United States

Dinesh Neupane United States

Ioanna Tsiligianni Greece

Murray Tilyard New Zealand

Alberto Freitas Portugal

Mendel E. Singer United States

Aurora Bueno‐Cavanillas Spain

Francisco Rivas‐Ruiz Spain

Marc B. Rosenman United States

Erin K. Sauber‐Schatz United States

Ronald J. Halbert United States

Andrea L. Schaffer

483 ×1.4

PHEOH

343 ×1.2

EPIDE

164 ×0.8

220 ×1.1

ONCOL

353 ×1.9

GHP

Citations per year, relative to Andrea L. Schaffer Andrea L. Schaffer (= 1×) peers Ronald J. Halbert

Countries citing papers authored by Andrea L. Schaffer

Since Specialization

Citations

This map shows the geographic impact of Andrea L. Schaffer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea L. Schaffer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea L. Schaffer more than expected).

Fields of papers citing papers by Andrea L. Schaffer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea L. Schaffer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea L. Schaffer. The network helps show where Andrea L. Schaffer may publish in the future.

Co-authorship network of co-authors of Andrea L. Schaffer

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea L. Schaffer. A scholar is included among the top collaborators of Andrea L. Schaffer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea L. Schaffer. Andrea L. Schaffer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Buckley, Nicholas A., et al.. (2025). The relative toxicity of medicines detected after poisoning suicide deaths in Australia, 2013–19: a data linkage case series study. The Medical Journal of Australia. 222(7). 339–347. 1 indexed citations

Zoëga, Helga, Michael O. Falster, M. Gillies, et al.. (2024). The Medicines Intelligence Data Platform: A Population‐Based Data Resource From New South Wales, Australia. Pharmacoepidemiology and Drug Safety. 33(8). e5887–e5887. 1 indexed citations

Deakin, Claire T., Juliana de Oliveira Costa, David Brieger, et al.. (2024). Post-discharge pharmacotherapy in people with atrial fibrillation hospitalized for acute myocardial infarction: an Australian cohort study 2018–22. European Heart Journal - Quality of Care and Clinical Outcomes. 11(3). 259–270.

Gisev, Natasa, Luke Buizen, Andrea L. Schaffer, et al.. (2023). Five-Year Trajectories of Prescription Opioid Use. JAMA Network Open. 6(8). e2328159–e2328159. 8 indexed citations

Carland, Jane E., Alexandra E. Stacy, Andrea L. Schaffer, et al.. (2023). Blood, dose recommendation reports and phone calls: Experiences of a therapeutic drug monitoring advisory service for vancomycin. British Journal of Clinical Pharmacology. 89(6). 1896–1902.

Costa, Juliana de Oliveira, Jialing Lin, Sallie‐Anne Pearson, et al.. (2023). Persistence and Adherence to Cardiovascular Medicines in Australia. Journal of the American Heart Association. 12(13). e030264–e030264. 9 indexed citations

Meier, Madeline H., et al.. (2023). The effects of the 4/20 cannabis holiday and adult-use cannabis legalization on medical cannabis sales and medical cannabis patient registration in Arizona. International Journal of Drug Policy. 114. 103974–103974. 4 indexed citations

Costa, Juliana de Oliveira, M. Gillies, Andrea L. Schaffer, et al.. (2022). Changes in antidepressant use in Australia: A nationwide analysis (2015–2021). Australian & New Zealand Journal of Psychiatry. 57(1). 49–57. 37 indexed citations

Costa, Juliana de Oliveira, et al.. (2022). Assessing the impact of implementing multiple adherence measures to antiretroviral therapy from dispensing data: a short report. AIDS Care. 35(7). 970–975. 1 indexed citations

10.

Costa, Juliana de Oliveira, et al.. (2021). The changing face of Australian data reforms: Impact on pharmacoepidemiology research. International Journal for Population Data Science. 6(1). 1418–1418. 11 indexed citations

11.

Gillies, M., David Burgner, Lorraine Ivancic, et al.. (2021). Changes in antibiotic prescribing following COVID‐19 restrictions: Lessons for post‐pandemic antibiotic stewardship. British Journal of Clinical Pharmacology. 88(3). 1143–1151. 40 indexed citations

12.

Cohen, Jacqueline M., Carolyn E. Cesta, Kari Furu, et al.. (2020). Prevalence trends and individual patterns of antiepileptic drug use in pregnancy 2006‐2016: A study in the five Nordic countries, United States, and Australia. Pharmacoepidemiology and Drug Safety. 29(8). 913–922. 36 indexed citations

13.

Chitty, Kate M., Jennifer Schumann, Andrea L. Schaffer, et al.. (2020). Australian Suicide Prevention using Health-Linked Data (ASHLi): Protocol for a population-based case series study. BMJ Open. 10(5). e038181–e038181. 10 indexed citations

14.

Stocker, Sophie L., Jane E. Carland, Stephanie E. Reuter, et al.. (2020). Evaluation of a Pilot Vancomycin Precision Dosing Advisory Service on Target Exposure Attainment Using an Interrupted Time Series Analysis. Clinical Pharmacology & Therapeutics. 109(1). 212–221. 18 indexed citations

15.

Costa, Juliana de Oliveira, Andrea L. Schaffer, Nicholas Medland, et al.. (2020). Adherence to Antiretroviral Regimens in Australia: A Nationwide Cohort Study. AIDS Patient Care and STDs. 34(2). 81–91. 11 indexed citations

16.

Tang, Mónica, Andrea L. Schaffer, Belinda E. Kiely, et al.. (2020). Correction: Treatment patterns and survival in HER2-positive early breast cancer: a whole-of-population Australian cohort study (2007–2016). British Journal of Cancer. 123(5). 868–868. 1 indexed citations

17.

Tang, Mónica, Andrea L. Schaffer, Belinda E. Kiely, et al.. (2019). Treatment patterns and survival in HER2-positive early breast cancer: a whole-of-population Australian cohort study (2007–2016). British Journal of Cancer. 121(11). 904–911. 12 indexed citations

18.

Vajdic, Claire M., Oscar Perez‐Concha, Joel Rhee, et al.. (2019). Health-related predictors of cancer registry-notified cancer of unknown primary site (CUP). Cancer Epidemiology. 61. 1–7. 5 indexed citations

19.

Gnjidic, Danijela, Sallie‐Anne Pearson, Sarah N. Hilmer, et al.. (2015). Manual versus automated coding of free-text self-reported medication data in the 45 and Up Study: a validation study. Public Health Research & Practice. 25(2). e2521518–e2521518. 3 indexed citations

20.

Ganda, Kirtan, Andrea L. Schaffer, Sallie‐Anne Pearson, & Markus J. Seibel. (2014). Compliance and persistence to oral bisphosphonate therapy following initiation within a secondary fracture prevention program: a randomised controlled trial of specialist vs. non-specialist management. Osteoporosis International. 25(4). 1345–1355. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact